ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT)

Saved in:
Bibliographic Details
Published inJournal of cystic fibrosis Vol. 21; pp. S43 - S44
Main Authors Braisdell, K., West, N.S.
Format Journal Article
LanguageEnglish
Published European Cystic Fibrosis Society 01.06.2022
Subjects
E-Poster Sessions
Online AccessGet full text

Cover

More Information
ISSN:1569-1993
1873-5010
DOI:10.1016/S1569-1993(22)00281-8